Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Assets: 2012-2025

Historic Return on Assets for Sunshine Biopharma (SBFM) over the last 8 years, with Sep 2025 value amounting to -0.19%.

  • Sunshine Biopharma's Return on Assets fell 5.00% to -0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.19%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.18% for FY2024, which is 2.00% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Return on Assets stood at -0.19%, which was up 8.42% from -0.21% recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Return on Assets high stood at -0.06% for Q3 2022, and its period low was -6.57% during Q3 2021.
  • Over the past 3 years, Sunshine Biopharma's median Return on Assets value was -0.17% (recorded in 2024), while the average stood at -0.38%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Assets spiked by 976bps in 2021, and later crashed by 89bps in 2023.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Return on Assets stood at -5.29% in 2021, then surged by 452bps to -0.76% in 2022, then spiked by 60bps to -0.16% in 2023, then decreased by 1bps to -0.17% in 2024, then dropped by 5bps to -0.19% in 2025.
  • Its Return on Assets was -0.19% in Q3 2025, compared to -0.21% in Q2 2025 and -0.17% in Q1 2025.